semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Head and Neck Cancer Covid19 Patient Care patient diagnosed with cancer of the upper aero digestive tract patient benefiting from a medical consultation patient benefiting from a multidisciplinary consultation meeting for treatment decision between 01/03/2020 and 28/02/2021  patient diagnosed with cancer other than upper aero digestive tract cancer patient whose treatment decision was made before 01/03/2020 (date considered as the beginning of the epidemic at the CHU Amiens-Picardie)
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  The Fixation Mainly Plays a Firm Role in the Tracheal Intubation and Reduces the Occurrence of Complications Patients with SICU intubation had been intubated for <8h at the time of entry (the interval of oral care was 8h) Patients with brain diseases or septic shock caused by abdominal infection There was no pulmonary infection before endotracheal intubation Facial skin integrity Good oral cavity: no odor, no residue, no oral diseases, oral mucosa integrity Informed consent is given by the family members and the informed consent is signed No adhesive tape allergy  Oral injury caused by suction Endotracheal intubation time < 48 h In the experiment is not willing to carry on the experiment, quit voluntarily
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-60.0,  Implant Stability Patients who have at least one missing tooth Patient with hyperlipidemia (LDL < 160 mg/dl ) Patients with sufficient interarch space Patients aged from 20 to 60 years old Good oral hygiene.(Wiesner et al. 2010) Accepts 6 months follow-up period (cooperative patients) Patient provides an informed consent  Patients with signs of acute infection related to the area of interest Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits (Lobbezoo et al. 2006) Current and former smokers (Lambert et al, 2000) Pregnant women Psychological problems -
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Necrotic Pulp Patient's age between 18-50 years. 2. Male and female. 3. Systemically healthy patients (ASA I or II). 4. Mature mandibular molar teeth with: Necrotic pulps, normal periapical radiographic appearance and no intra-canal calcifications or internal resorptive lesions  Medically compromised patients having substantive functional limitations (ASA III or IV). 2. Patients having two or more adjacent teeth requiring endodontic treatment. 3. Patients who received antibiotic therapy within the last three months before treatment. 4. Patients administered analgesics in the last 24 hours before treatment. 5. Teeth with Vital pulps Immature apices Acute periapical abscess, swellings and facial cellulitis Periodontally hopeless (mobility grade II or III) Previous root canal treatment Non-restorable coronal portion. 6. TMJ problems, bruxism or traumatic occlusion. 7. Inability to perceive the given instructions
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 16.0-999.0,  Venomous Snakebites Local Anesthesia Painless Injection Regional Anesthesia Dermatologic Surgery Cutaneous Pain Musculoskeletal Pain All volunteer subjects will be healthy, mature in behavior and temperament, without mental impairment and at least 16 years of age A volunteer TLE research subject must be a non-medical-professional layperson and must have signed an IRB-approved informed consent form prior to participation All subjects must weigh at least 40kg = 88lb  Anyone who has a significant fear of needles or fear of injections A history of lidocaine allergy A significant history of epinephrine hypersensitivity History of an adverse reaction to percutaneous injections, such as fainting and lightheadedness (vasovagal reactions, near syncope) Significant needle phobia or anxiety Vasovagal reaction associated with any medical procedures or the sight of blood Uncontrolled or labile hypertension Hyperthyroidism, thyroid medications Recent phenylephrine (Actifed®) or pseudoephedrine use Any significant cardiac arrhythmia including controlled atrial fibrillation tachycardia, mitral valve prolapse
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Idiopathic Retroperitoneal Fibrosis age 18-75 diagnosed as IRPF. The diagnosis of idiopathic retroperitoneal fibrosis is based on the following aspects :(1) the swelling of retroperitoneal tissue , which seems neoplastic; (2) A large number of lymphocytes proliferated and infiltrated in the affected tissues and organs, and tissues showed inflammation, fibrosis and sclerosis, in which IgG4-positive cells accounted for less than 50% of plasma cells; (3) Increased inflammatory markers, such as ESR and CRP; (4) Good response to glucocorticoid therapy  malignancy retroperitoneal fibrosis secondary to other diseases or drugs or abdominal surgeries
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 6.0-12.0,  Cost Effectiveness • Healthy children with no physical or mental disorders. Children with newly fully erupted permanent molars (PMs)  Teeth will be excluded from the study if they had any of the following Dental caries in dentine History of pain or swelling. Parents refused their children participate in the trial
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-70.0,  Cervicogenic Headache • Both Genders Age between 20 to 75 Years Neck pain referring the unilateral pain to the sub-occipital region and head Headache intensifying upon manual pressure to upper cervical joints and muscles With the cranio-cervical Flexion rotation exam, neck pain and ipsilateral headache and restriction of C1 and C2 rotation  • Tension headache (Headache on both sides) If the patient not tolerate the cranio-cervical Flexion rotation test Patients presents with autonomic symptoms like visual disturbance, vertigo, dizziness If the physiotherapeutic modalities used for head pain in the last 6 months Headache other than cervical origins Clinically diagnosed as case of cervical radiculopathy or myelopathy Extreme cervical discomfort due to disk herniation, stenosis of the spinal canal and cervical arthritis Each other disorder that may be contraindicated in the upper cervical area of myofascial release
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Facial Pain Temporomandibular Disorder Temporomandibular Joint Disorders Temporomandibular; Functional Disturbance Orofacial pain in the joint or muscles, degree NRS≥3 Clicking phenomenon during TMJ opening or closing movement Deviation movement during opening of the lower jaw Legal competence and presence of the signed declaration of consent  Drug abuse Depression Polyarthritis
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 50.0-85.0,  Total Knee Arthroplasty Scheduled to undergo a primary, unilateral total knee arthroplasty secondary to end-stage osteoarthritis  Discharge to location other than home after surgery History of heart failure, lymphatic insufficiency, hepatic disease, pre-existing pitting edema, varicose vein ligation or any other condition associated with lower extremity swelling Unstable orthopedic conditions (besides OA/TKA) that limit function Other neurological, vascular, or cardiac problems that limit function or cause chronic lower extremity swelling No caregiver or inability to touch toes which can affect the ability to don/doff the compression garment Current smoker or history of substance abuse Surgical complication necessitating an altered course of rehabilitation Uncontrolled diabetes (hemoglobin A1c level >8.0) Body mass index >40 kg/m2
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Sleep Hygiene Reside in Harrison County of West Virginia Ability to read and understand English Ability to provide informed consent  Inability to read and understand English Inability or unwillingness to provide informed consent Presence of sleep apnea Depression Severe insomnia Using prescription sleeping medication or narcotics Acute illness including stroke, heart attack, heart failure or pneumonia with or without COVID-19 infection requiring hospital admission within the last 8 weeks
Patient description: The patient is a 53-year-old man complaining of frequent headaches, generalized bone pain and difficulty chewing that started 6 years ago and is getting worse. Examination shows bilateral swellings around the molars. The swellings have increased since his last examination. Several extraoral lesions of the head and face are detected. The swellings are non-tender and attached to the underlying bone. Further evaluation shows increased uptake of radioactive substance as well as an increase in urinary pyridinoline. The serum alkaline phosphatase is 300 IU/L (the normal range is 44- 147 IU/L). The patient's sister had the same problems. She was diagnosed with Paget's disease of bone when she was 52 years old. The diagnosis of Paget's Disease of Bone is confirmed and Bisphosphonate will be started as first-line therapy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-99.0,  Alveolar Osteitis (1) > 18 years; (2) untreated AO after extraction of a permanent tooth (excluding wisdom teeth); and (3) diagnosis of AO based on the of Blum (Blum 2002)  (1) patients with chronic diseases and/or taking any medication, influencing hard and soft tissue healing; (2) pregnancy; (3) history of hypersensitivity or allergy to HY; (4) inability to attend follow-up appointments; (5) intake of preoperative antibiotics
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.083-999.0,  Movement Disorder Any volunteer of any age from birth to old age who is deemed medically fit to participate and is willing to provide their informed consent will be included in the study
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Parkinson's Disease Individuals age 18 or over from families in which an autosomal dominant form of Parkinson's disease is apparently being inherited. The diagnosis must be supported by accepted clinical tremor, bradykinesia, and responsiveness to L-DOPA. Unaffected family members will also be enrolled. Subjects must give consent. Parkinson's disease may be associated with dementia. Decisionally-impaired individuals will be enrolled
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Parkinson's Disease Individuals over the age of 18 from families in which there are three or more individuals affected with Parkinson's disease (within three generations) and the proband was the only affected person available or willing to participate in the study The diagnosis must be supported by accepted clinical tremor, bradykinesia, and responsiveness to L-DOPA. PD may be associated with dementia. The study will lose power if individuals with mental impairment and PD are excluded. For this reason, decisionally-impaired individuals will be enrolled  No one under 18 will be enrolled because, with the exception of the rare autosomal recessive PD due to parkin mutations, PD does not affect minors. Study design does not involve testing fetuses
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Cerebellar Disease Dementia Healthy Parkinson's Disease Right handed normal volunteers (18-65 years old). Patients with Parkinson's disease off medication. Patients with cerebellar deficits. Patients with frontal lobe lesions. Patients with frontal lobe dementia  Subjects with personal or family history of seizures or other neurological disorders. Pregnant women. Volunteers or patients with severe coronary artery disease. Metal in the cranium except mouth. Intracardiac lines. Increased intracranial pressure as evaluated by clinical means. Cardiac pacemakers. Intake of neuroleptics